Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-14-Speech-3-039"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20011114.2.3-039"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, first of all I should like to thank Commissioner Busquin for his extraordinary commitment and for the enthusiasm he has managed to raise in the European Parliament for the creation of a European Research Area. I should also like to thank the rapporteur, Mr Caudron, as well as the shadow rapporteurs, Mr Van Velzen and Mrs McNally, for their contributions and the respect they have shown towards those individual Members who have sought to improve this framework programme with their amendments.
The text originally proposed by the Commission has been considerably supplemented and rejigged, now both specifying more clearly the research priorities in Europe in the various sectors and rejigging the initial financial architecture. With regard to the biomedical sector, I must express my satisfaction with the EUR 500 million increase given to biomedicine, not just for genome and post-genome research but for all research aimed at adding to our understanding of the molecular mechanisms at the basis of diseases as well.
I should like once again to affirm a fundamental idea already expressed by Mr Trakatellis, which is that no research in Europe can be more important or deserve greater priority than that which concerns people’s health and their physical and mental suffering. That is why I now ask Commissioner Busquin, on behalf of the whole scientific community and of a number of Nobel prize-winners, such as my friend Renato Dulbecco, Rita Levi Montalcini and John Vane, to maintain this increase in funding for biomedical research for the next five years.
Through scientific research we can at last, thanks to new technologies, combat terrible, hitherto incurable diseases such as cancer, AIDS, Alzheimer’s, Creutzfeld-Jakob disease, heart disease and so on, not least by using advanced technologies, as specified, for instance, in the Trakatellis, Purvis and Nisticò amendment, which embodies a good balance that should gain the consensus of the whole House."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples